-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Terns Pharma, Raises Price Target to $54

Benzinga·12/09/2025 13:47:32
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Terns Pharma (NASDAQ:TERN) with a Outperform and raises the price target from $33 to $54.